These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11886399)

  • 1. Plasma exchange as a source of protein C for acute onset protein C pathway failure.
    Hodgson A; Ryan T; Moriarty J; Mellotte G; Murphy C; Smith OP
    Br J Haematol; 2002 Mar; 116(4):905-8. PubMed ID: 11886399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
    Ettingshausen CE; Veldmann A; Beeg T; Schneider W; Jäger G; Kreuz W
    Semin Thromb Hemost; 1999; 25(6):537-41. PubMed ID: 10632475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Saved case of purpura fulminans in pneumococcal sepsis after splenectomy].
    Susa K; Ebata A; Sugawara T; Hyun S; Toriumi Y; Sakuma I; Takayama K; Imai A; Watanabe M
    Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):778-80. PubMed ID: 17506318
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans.
    Smith OP; White B; Vaughan D; Rafferty M; Claffey L; Lyons B; Casey W
    Lancet; 1997 Nov; 350(9091):1590-3. PubMed ID: 9393338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia.
    White B; Livingstone W; Murphy C; Hodgson A; Rafferty M; Smith OP
    Blood; 2000 Dec; 96(12):3719-24. PubMed ID: 11090052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
    de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
    Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of purpura fulminans is caused by homozygous delta8857 mutation (protein C-nagoya) and successfully treated with activated protein C concentrate.
    Nakayama T; Matsushita T; Hidano H; Suzuki C; Hamaguchi M; Kojima T; Saito H
    Br J Haematol; 2000 Sep; 110(3):727-30. PubMed ID: 10997987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purpura fulminans skin lesions in a newborn with complete protein C deficiency.
    Paret G; Barzilai A; Barzilay Z
    J Pediatr; 1998 Mar; 132(3 Pt 1):558. PubMed ID: 9544924
    [No Abstract]   [Full Text] [Related]  

  • 9. Activated protein C concentrate reverses purpura fulminans in severe genetic protein C deficiency.
    Manco-Johnson MJ; Knapp-Clevenger R
    J Pediatr Hematol Oncol; 2004 Jan; 26(1):25-7. PubMed ID: 14707707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of protein C concentrate to treat purpura fulminans and thromboembolic events in severe congenital protein C deficiency.
    Manco-Johnson MJ; Bomgaars L; Palascak J; Shapiro A; Geil J; Fritsch S; Pavlova BG; Gelmont D
    Thromb Haemost; 2016 Jul; 116(1):58-68. PubMed ID: 27052576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].
    Llinares Tello F; Hernández Prats C; Burgos San José A; Bosacoma Ros N; Alcalá Minagorre P; López Rodríguez F; Reig Sáenz R; Marco Vera P; Ordovás Baines JP
    Farm Hosp; 2004; 28(2):130-6. PubMed ID: 15101805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-C concentrate for meningococcal purpura fulminans.
    Kreuz W; Veldman A; Escuriola-Ettingshausen C; Schneider W; Beeg T
    Lancet; 1998 Mar; 351(9107):986-7; author reply 988. PubMed ID: 9734967
    [No Abstract]   [Full Text] [Related]  

  • 13. [Purpura fulminans due to pneumococcal pneumonia in a healthy adult: a case report].
    Takada K; Matsumoto S; Hiramatsu T; Kojima E; Watanabe H
    Kansenshogaku Zasshi; 2007 Mar; 81(2):194-9. PubMed ID: 17447479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin).
    Schellongowski P; Bauer E; Holzinger U; Staudinger T; Frass M; Laczika K; Locker GJ; Quehenberger P; Rabitsch W; Schenk P; Knöbl P
    Vox Sang; 2006 May; 90(4):294-301. PubMed ID: 16635072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory gram-negative septic shock complicated by extended purpura fulminans and multiple organ failure in a 23-year-old puerpera -a case report.
    Viderman D; Umbetzhanov Y; Temirov T; Kuzkov VV
    Korean J Anesthesiol; 2021 Jun; 74(3):266-270. PubMed ID: 32689761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purpura fulminans due to Stenotrophomonas maltophilia infection in a premature infant.
    Aygun AD; Akarsu S; Kilic M; Ozdiller S; Toprakli I
    Pediatr Int; 2006 Jun; 48(3):346-8. PubMed ID: 16732810
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of protein C concentrate in adult patients with severe sepsis and septic shock].
    Baratto F; Michielan F; Gagliardi G; Di Gregorio G; Pasqualetto A; Meroni M; Giron GP
    Minerva Anestesiol; 2004 May; 70(5):351-6. PubMed ID: 15181415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal purpura fulminans successfully treated with activated protein C.
    Minhas KM; Bashir S; Sarwari AR; Parker J
    South Med J; 2008 Oct; 101(10):1046-8. PubMed ID: 18791506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purpura Fulminans: Mechanism and Management of Dysregulated Hemostasis.
    Colling ME; Bendapudi PK
    Transfus Med Rev; 2018 Apr; 32(2):69-76. PubMed ID: 29157918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein C in the treatment of coagulopathy in meningococcal disease.
    Rintala E; Seppälä OP; Kotilainen P; Pettilä V; Rasi V
    Crit Care Med; 1998 May; 26(5):965-8. PubMed ID: 9590329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.